S023 Psoriasis: Modern Therapeutic Approaches
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This is a comprehensive overview of the latest information related to psoriasis and its therapy. An emphasis will be on oral and biologic therapies, treatment of mild-to-moderate psoriasis and special areas, early intervention, the comorbidities of psoriasis, and the impact of therapy on those comorbidities.
This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuing Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org.
LEARNING OBJECTIVES
Measure the effects of modern therapies on the comorbidities associated with psoriasis.
Describe the treatment approach to psoriasis regardless of body surface area of involvement, and understand the impact of special areas of involvement on quality of life.
Differentiate the use of modern therapies for psoriasis and their placement in the treatment arsenal.
SCHEDULE
2:00 PM
Update on Therapies for Psoriasis: Current and Pipeline
Bruce Elliot Strober, MD, PhD, FAAD
2:25 PM
Early Treatment of Psoriasis: A Window of Opportunity?
Richard G. B. Langley, MD, FAAD
2:50 PM
Real World Therapy Selection in Psoriasis
Mona Shahriari, MD, FAAD
3:15 PM
Therapies for Hard-to-Treat Psoriasis
Jeffrey Marcus Cohen, MD, FAAD
3:40 PM
What's the Big Deal? Exploring the Link Between Psoriasis and Obesity
Jennifer Soung, MD, FAAD
4:05 PM
Translating AAD/NPF Guidelines to Your Clinical Practice to Lower Cardiovascular Risk in Patients with Psoriasis
Joel M. Gelfand, MD, MSCE, FAAD
4:30 PM
The Dermatologist’s Guide to Psoriatic Arthritis
Kenneth B. Gordon, MD, FAAD
SPEAKERS
Jeffrey Marcus Cohen, MD, FAAD
Joel M. Gelfand, MD, MSCE, FAAD
Kenneth B. Gordon, MD, FAAD
Richard G. B. Langley, MD, FAAD
Mona Shahriari, MD, FAAD
Jennifer Soung, MD, FAAD
Bruce Elliot Strober, MD, PhD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Jeffrey Marcus Cohen, MD, FAAD
Advarra – Data Safety Monitoring Board(Fees); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Honoraria); Logical Images, Inc – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Fees); Sanofi – Consultant (1099 relationship)(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria);
Joel M. Gelfand, MD, MSCE, FAAD
AbbVie – Consultant(Fees); Amgen – Investigator(Grants/Research Funding); Artax Biopharma – Data Safety Monitoring Board(Fees); BMS – Consultant(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); CellDex – Data Safety Monitoring Board(Fees); Daavlin Company – Other(Equipment); FIDE – Consultant(Fees); Healio – Other(Fees); Inmagene Biopharmaceuticals – Data Safety Monitoring Board(Fees); International Psoriasis Council – Board of Directors(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Leo Pharma Inc – Consultant(Fees); Maui Derm – Speaker/Faculty Education(Fees); Medical Dermatology Society – Board of Directors(No Compensation Received); Moonlake – Data Safety Monitoring Board(Fees); National Psoriasis Foundation – Investigator(Grants/Research Funding); Neuroderm LTD – Other(Fees); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); UCB – Other(Fees); Veolia North America – Consultant(Fees);
Kenneth B. Gordon, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria); Othro Dermatologics – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Protagonist Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);
Richard G. B. Langley, MD, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Amgen – Investigator(Grants/Research Funding), Speaker(Honoraria); Astellas Pharma US, Inc – Investigator(Grants/Research Funding); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Celgene Corporation – Advisory Board(Honoraria); Centocor Ortho Biotech Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Honoraria); Genentech, Inc. – Investigator(Grants/Research Funding); Isotechnika Pharma Inc. – Investigator(Grants/Research Funding); LEO Laboratories Ltd (LEO Pharma) – Investigator(Grants/Research Funding); Merck Serono – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding), Speaker(Honoraria); UCB – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Mona Shahriari, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Speaker(Honoraria); Bristol-Myers Squibb – Speaker(Honoraria); CoreEvitas, LLC – Advisory Board(Honoraria), Investigator(Fees); Dermavant Sciences – Investigator(Grants/Research Funding), Speaker(Honoraria); Eli Lilly and Company – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Galderma – Advisory Board(Honoraria), Speaker(Honoraria); Incyte Corporation – Advisory Board(Honoraria); Janssen Biotech – Consultant(Honoraria), Speaker/Faculty Education(Honoraria); LEO Pharma, US – Consultant(Honoraria), Speaker/Faculty Education(Honoraria); National Psoriasis Foundation – Speaker/Faculty Education(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Sanofi/Regeneron – Consultant(Honoraria), Speaker(Honoraria); UCB – Consultant(Honoraria), Speaker(Honoraria);
Jennifer Soung, MD, FAAD
AbbVie – Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Alumis – Investigator(Grants/Research Funding); Amgen – Speaker(Honoraria); Arcutis, Inc. – Consultant(Honoraria); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Boehringer Ingelheim – Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Bristol Myers Squibb – Consultant (1099 relationship)(Honoraria); Castle Biosciences – Investigator(Grants/Research Funding); Celgene – Advisory Board(Honoraria); Coval biopharma – Consultant (1099 relationship)(Grants/Research Funding); Dermavant Sciences – Consultant(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Evelo Biosciences, Inc. – Advisory Board(Honoraria); Galderma USA – Investigator(Grants/Research Funding); Incyte – Consultant (1099 relationship)(Honoraria); Incyte Corporation – Speaker/Faculty Education(Honoraria); Janssen Biotech – Investigator(Grants/Research Funding), Speaker(Honoraria); Kobio Labs – Independent Contractor(Honoraria), Investigator(Fees); Kyowa Hakko Kirin Pharma, Inc. – Investigator(Grants/Research Funding); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Honoraria), Investigator(Grants/Research Funding); LEO Pharma, US – Speaker/Faculty Education(Honoraria); Menlo Therapeutics – Investigator(Grants/Research Funding); National Psoriasis Foundation – Speaker/Faculty Education(Honoraria); Novartis – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Ortho Dermatologics – Consultant(Honoraria), Speaker(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding), Speaker(Honoraria); Regeneron – Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); UCB – Consultant(Honoraria), Investigator(Grants/Research Funding);
Bruce Elliot Strober, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Alumis – Consultant(Fees); Amgen – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant(Fees), Speaker(Honoraria); Boehringer Ingelheim – Consultant(Honoraria); Bristol Myers Squibb – Speaker(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Connect Biopharma LLC – Stockholder(Other Financial Benefit); CoreEvitas, LLC – Advisory Board(Honoraria), Investigator(Fees); Dermavant Sciences, Inc. – Consultant(Fees), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Janssen Biotech – Speaker(Honoraria); Janssen-Ortho Inc. – Advisory Board(Honoraria), Consultant(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Honoraria); Meiji Seika Pharma Co., Ltd – Consultant(Fees); Mindera – Stockholder(Other Financial Benefit); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Consultant(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria); Pfizer Inc. – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); UCB – Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria); Union Therapeutics – Consultant(Fees);